Articles in section Licensing
| << Joint Venture | 543 articles | Mergers & Acquisitions >> |
| Pages 1 2 3 4 5 .. 55 | Next >> |
-
Innovent Signs US$1.1B Licensing Alliance with Spero for IBI355 (SP001), for the Teatment Immune-Mediated Diseases
-
AstraZeneca Signs US$2.1 B Respiratory Disease Licensing Agreement with Sino Biopharmaceutical for TQC3721
-
Madrigal Pharmaceuticals Inks US$1 B pact with Arrowhead Pharmaceuticals to Advance RNAi Therapy for MASH
-
Madrigal Pharmaceuticals Strikes Global Licensing Pact with Suzhou Ribo Life Science to Advance siRNA Metabolic Programmes
-
Madrigal Inks US$50 M Deal with Pfizer for DGAT-2 inhibitor Ervogastat for the Treatment of MASH
-
Pfizer Secures US$2.09 B Licensing Agreement for YaoPharma’s Weight Management Candidate
-
Gilead’s Kite Signs US$1.64 B In Vivo CAR-T Deal with Pregene Biopharma
-
Novo Nordisk Expands Rare Disease Pipeline with US$2.4 B Omeros Partnership
-
AbbVie Signs US$1.225 B Licensing Pact with IGI Therapeutics for Oncology and Autoimmune Disease Treatment
-
Gilead Sciences Inks US$750 M Deal with Kymera Therapeutics for Novel Oral Molecular Glue CDK2 Degraders
PharmaDeals will be moved to a new platform by October 31, 2026. Please look out for an email from your IQVIA account manager by the end of September with details.
RSS